Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Epidermal Growth

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Medicine ◽

10.1097/md.0000000000002239 ◽

2015 ◽

Vol 94 (50) ◽

pp. e2239 ◽

Cited By ~ 4

Author(s):

Yu-Mu Chen ◽

Chien-Hao Lai ◽

Huang-Chih Chang ◽

Tung-Ying Chao ◽

Chia-Cheng Tseng ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Mutant

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

Cancers ◽

10.3390/cancers3022667 ◽

2011 ◽

Vol 3 (2) ◽

pp. 2667-2678 ◽

Cited By ~ 4

Author(s):

Shih-Chieh Chang ◽

Cheng-Yu Chang ◽

Jin-Yuan Shih

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Current Opinion in Oncology ◽

10.1097/cco.0000000000000495 ◽

2019 ◽

Vol 31 (1) ◽

pp. 1-7 ◽

Cited By ~ 9

Author(s):

Julia Roeper ◽

Frank Griesinger

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Role of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Bronchoalveolar Carcinoma

Clinical Lung Cancer ◽

10.3816/clc.2004.s.014 ◽

2004 ◽

Vol 6 ◽

pp. S43-S47 ◽

Cited By ~ 3

Author(s):

Jyoti D. Patel

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action

Oncology Letters ◽

10.3892/ol.2012.994 ◽

2012 ◽

Vol 5 (1) ◽

pp. 19-24 ◽

Cited By ~ 4

Author(s):

YAPING XU ◽

LIMING SHENG ◽

WEIMIN MAO

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Mechanisms Of Action ◽

Epidermal Growth ◽

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities

Asia-Pacific Journal of Oncology Nursing ◽

10.4103/apjon.apjon_28_17 ◽

2017 ◽

Vol 4 (4) ◽

pp. 323 ◽

Cited By ~ 1

Author(s):

PhilomenaCharlotte Dsouza ◽

Shiyam Kumar

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Systemic Antibiotics ◽

Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Indian Journal of Cancer ◽

10.4103/ijc.ijc_505_17 ◽

2017 ◽

Vol 54 (5) ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

A Pathak ◽

S Rajappa ◽

A Gore

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

450P Impact of baseline, trend, and normalization of carcinoembryonic antigen on survival in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors

Annals of Oncology ◽

10.1093/annonc/mdv532.34 ◽

2015 ◽

Vol 26 ◽

pp. ix125

Author(s):

Y.-M. Chen ◽

C.-H. Lai ◽

M.-C. Lin

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Mutant

First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?

Current Opinion in Oncology ◽

10.1097/cco.0b013e328341ee26 ◽

2011 ◽

Vol 23 (2) ◽

pp. 131-132 ◽

Cited By ~ 1

Author(s):

Cesare Gridelli

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Epidermal Growth ◽

First Line Treatment

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

BMC Cancer ◽

10.1186/s12885-016-2917-6 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 2

Author(s):

Yu-Mu Chen ◽

Chien-Hao Lai ◽

Kun-Ming Rau ◽

Cheng-Hua Huang ◽

Huang-Chih Chang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Inflammatory Status ◽

Epidermal Growth ◽

Receptor Mutant